Scarica l'app Stockscreener
136.01
0.47%
-0.64
Dopo l'orario di chiusura:
136.01
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
First Week of April 17th Options Trading For Jazz Pharmaceuticals - Nasdaq
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Bought by Venturi Wealth Management LLC - MarketBeat
Van ECK Associates Corp Reduces Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Can Jazz Pharmaceuticals' Next Strategic Move Transform Its $2B Portfolio? Key Insights Coming - StockTitan
Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Autism Spectrum Disorder Treatment Market Size is expected - openPR
Convergence Investment Partners LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Philip James Wealth Mangement LLC Has $1.31 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals (JAZZ) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) Hits New 1-Year HighStill a Buy? - MarketBeat
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline - MSN
Jazz Pharmaceuticals (NASDAQ:JAZZ) Upgraded at Wells Fargo & Company - MarketBeat
Summit Trail Advisors LLC Takes $539,000 Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Warther Private Wealth LLC Sells 31,065 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) Shares Up 6.2%What's Next? - MarketBeat
Harvey Capital Management Inc. Purchases Shares of 25,450 Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Moloney Securities Asset Management LLC Takes $464,000 Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Polaris Capital Management LLC Reduces Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals stock hits 52-week high of $134.24 By Investing.com - Investing.com Australia
Lewy Body Dementia Pipeline 2025: FDA Approvals and Clinical - openPR
Wells Fargo Upgrades Jazz Pharmaceuticals to Overweight From Equalweight, Adjusts Price Target to $170 From $130 - Marketscreener.com
Wells Fargo Upgrades Jazz Pharmaceuticals (BRSE:J7Z) - Nasdaq
This AstraZeneca Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Wells Fargo Upgrades Jazz Pharmaceuticals (JAZZ) - Nasdaq
Deep Dive Into Jazz Pharmaceuticals Stock: Analyst Perspectives (9 Ratings) - Benzinga
Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN
Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains? - Nasdaq
Graphene Investments SAS Cuts Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 - ShareCast
Jazz Pharmaceutical wraps up Epidiolex patent claims - Green Market Report
Jazz Pharma Drops Last Defendant From Epidiolex Patent Suit - Law360
Avadel Pharmaceuticals gains as holder pushes for sale process (AVDL:NASDAQ) - Seeking Alpha
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors - Yahoo Finance
Meritage Portfolio Management Has $8.16 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Bruce C. Cozadd Sells 1,500 Shares of Stock - MarketBeat
Fed Circ. Considers Some Testing For Avadel Sleep Drug - Law360
Jazz Pharmaceuticals: Turning the Tables on Cancer with The - CSRwire.com
Jazz Pharmaceuticals Joins the Movement for Awareness and Suppor - GuruFocus.com
Jazz Pharmaceuticals Joins the Movement for Awareness and Support on World Cancer Day with The Upside Down Challenge - StreetInsider.com
Jazz Pharmaceuticals CEO Bruce Cozadd sells shares worth $183,465 - MSN
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Sees Large Decrease in Short Interest - MarketBeat
Institute for Wealth Management LLC. Makes New $260,000 Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):